Last $0.0080 USD
Change Today 0.00 / 0.00%
Volume 0.0
NEUN On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/11/14 All times are local (Market data is delayed by at least 15 minutes).

neurogenesis inc (NEUN) Snapshot

Open
$0.0080
Previous Close
$0.0080
Day High
$0.0080
Day Low
$0.0080
52 Week High
09/4/13 - $0.09
52 Week Low
11/22/13 - $0.0030
Market Cap
463.0K
Average Volume 10 Days
76.1K
EPS TTM
--
Shares Outstanding
57.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEUROGENESIS INC (NEUN)

Related News

No related news articles were found.

neurogenesis inc (NEUN) Related Businessweek News

No Related Businessweek News Found

neurogenesis inc (NEUN) Details

NeuroGenesis, Inc. engages in the development of a series of products to be used as adjuncts to therapy by the substance-abuse treatment community. Neurotransmitters are chemicals that allow communication to occur in the brain. The company offers NeuBecalm'd, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress; and NeuRecover, a nutritional support for the natural replenishment of neurotransmitters depleted by the long-term use of alcohol. It also provides NeuRelieve, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of antianxiety drugs, and to be used in conjunction with professional support during the tapering process; NeuReplenish for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of chemical stimulants; and NeuSlim, which aids in the reduction of cravings (or urges) for simple carbohydrates, to reduce excessive appetite in general, and to assist in healthy moderation of nutritional needs. In addition, the company offers The Combo, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the prolonged use of prescription pain pills or from the use of opiate drugs, including heroin or methadone, as well as used in conjunction with professional support during the tapering process; and Encore Optima, a nutritional support to enhance the body's immune response. It markets it products to rehabilitation hospitals and clinics worldwide. The company was founded in 1984 and headquartered in League City, Texas.

neurogenesis inc (NEUN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEUN:US $0.01 USD 0.00

NEUN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEUN.
View Industry Companies
 

Industry Analysis

NEUN

Industry Average

Valuation NEUN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROGENESIS INC, please visit www.neurogenesis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.